Preoperative Evaluation of Renal Cell Carcinoma by Using 18F-FDG PET/CT

Clinical Nuclear Medicine - Tập 40 Số 12 - Trang 936-940 - 2015
Miwako Takahashi1, Haruki Kume2,3,4, Keitaro Koyama1, Tohru Nakagawa2,3,4, Tetsuya Fujimura2,3,4, Teppei Morikawa2,3,4, Masashi Fukayama2,3,4, Yukio Homma2,3,4, Kuni Ohtomo1, Toshimitsu Momose1,5
1Division of Nuclear Medicine, Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, †Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, and ‡Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
2Department of Radiology, University of Tokyo, 3-1 Hongo 7-Chome, Bunkyo-ku, Tokyo 113-8655, Japan.
3Division of Nuclear Medicine
4Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
5Toshimitsu Momose, MD, Division of Nuclear Medicine, Department of Radiology, University of Tokyo, 3–1 Hongo 7-Chome, Bunkyo-ku, Tokyo 113–8655, Japan. E-mail: [email protected].

Tóm tắt

Từ khóa


Tài liệu tham khảo

Chow, 2010, Epidemiology and risk factors for kidney cancer., Nat Rev Urol, 7, 245, 10.1038/nrurol.2010.46

Rosales, 2010, Active surveillance for renal cortical neoplasms., J Urol, 183, 1698, 10.1016/j.juro.2010.01.024

Gontero, 2013, Active surveillance for small renal tumors: have clinical concerns been addressed so far Int J Urol., , 20, 356

Endo, 2008, Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors., Lung Cancer, 61, 350, 10.1016/j.lungcan.2008.01.003

Heudel, 2010, Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors., Int J Clin Oncol, 15, 588, 10.1007/s10147-010-0120-3

Kadota, 2012, FDG-PET SUVmax combined with IASLCATSERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma., Ann Surg Oncol, 19, 3598, 10.1245/s10434-012-2414-3

Watanabe, 2013, 18 F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential., Int J Hematol, 97, 43, 10.1007/s12185-012-1225-4

Rakheja, 2012, Correlating metabolic activity on 18 F-FDG PETCT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients., AJR Am J Roentgenol, 198, 1409, 10.2214/AJR.11.7560

Kaschten, 1998, Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose andor carbon-11-methionine., J Nucl Med, 39, 778

Borgwardt, 2005, Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomographymagnetic resonance imaging coregistration and image fusion., J Clin Oncol, 23, 3030, 10.1200/JCO.2005.02.074

Kubota, 2014, Lesion-based analysis of (18)F-FDG uptake and (111)In-Pentetreotide uptake by neuroendocrine tumors., Ann Nucl Med, 28, 1004, 10.1007/s12149-014-0900-3

Torizuka, 1995, In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET., J Nucl Med, 36, 1811

Aide, 2003, Efficiency of (18)FFDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT., Eur J Nucl Med Mol Imaging, 30, 1236, 10.1007/s00259-003-1211-4

Ozulker, 2011, A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomographycomputed tomography in the evaluation of indeterminate renal masses., Nucl Med Commun, 32, 265, 10.1097/MNM.0b013e3283442e3b

Ho, 2012, Dual-tracer PETCT in renal angiomyolipoma and subtypes of renal cell carcinoma., Clin Nucl Med, 37, 1075, 10.1097/RLU.0b013e318266cde2

Gudbjartsson, 2005, Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients., Eur Urol, 48, 593, 10.1016/j.eururo.2005.04.016

Volpe, 2010, Prognostic factors in renal cell carcinoma., World J Urol, 28, 319, 10.1007/s00345-010-0540-8

Ficarra, 2005, Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma., Cancer, 103, 68, 10.1002/cncr.20749

Fuhrman, 1982, Prognostic significance of morphologic parameters in renal cell carcinoma., Am J Surg Pathol, 6, 655, 10.1097/00000478-198210000-00007

Rioux-Leclercq, 2007, Prognostic ability of simplified nuclear grading of renal cell carcinoma., Cancer, 109, 868, 10.1002/cncr.22463

Ferda, 2013, 18 F-FDG-PETCT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation., Anticancer Res, 33, 2665

Ramdave, 2001, Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma., J Urol, 166, 825, 10.1016/S0022-5347(05)65845-4

Miyakita, 2002, Significance of 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer., Int J Urol, 9, 15, 10.1046/j.1442-2042.2002.00416.x

Kang, 2004, Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma., J Urol, 171, 1806, 10.1097/01.ju.0000120241.50061.e4

Kumar, 2005, 2-Deoxy-2-F-18fluoro-D-glucose-positron emission tomography in characterization of solid renal masses., Mol Imaging Biol, 7, 431, 10.1007/s11307-005-0026-z

Nakhoda, 2013, Assessment of the diagnostic performance of (18)F-FDG-PETCT for detection and characterization of solid renal malignancies., Hell J Nucl Med, 16, 19

Oyama, 2014, Diagnosis of complex renal cystic masses and solid renal lesions using PET imaging: comparison of 11C-acetate and 18 F-FDG PET imaging., Clin Nucl Med, 39, e208, 10.1097/RLU.0000000000000287

Zokalj, 2014, Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches., Int Urol Nephrol, 46, 1089, 10.1007/s11255-013-0631-8

Kim, 2002, Differentiation of subtypes of renal cell carcinoma on helical CT scans., AJR Am J Roentgenol, 178, 1499, 10.2214/ajr.178.6.1781499

Lidgren, 2008, Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha., BJU Int, 101, 480

Suganuma, 2007, Differential expression of facilitative glucose transporters in normal and tumour kidney tissues., BJU Int, 99, 1143, 10.1111/j.1464-410X.2007.06765.x

Aparicio, 2010, Glucose transporter expression and the potential role of fructose in renal cell carcinoma: A correlation with pathological parameters., Mol Med Rep, 3, 575, 10.3892/mmr_00000300

Gerich, 2001, Renal gluconeogenesis: its importance in human glucose homeostasis., Diabetes Care, 24, 382, 10.2337/diacare.24.2.382

Toro, 2003, Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America., Am J Hum Genet, 73, 95, 10.1086/376435

Isaacs, 2005, HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability., Cancer Cell, 8, 143, 10.1016/j.ccr.2005.06.017

Waldert, 2008, Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC., BJU Int, 102, 1381

Soret, 2007, Partial-volume effect in PET tumor imaging., J Nucl Med, 48, 932, 10.2967/jnumed.106.035774

Divgi, 2013, Positron emission tomographycomputed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial., J Clin Oncol, 31, 187, 10.1200/JCO.2011.41.2445

Shreve, 1995, Carbon-11-acetate PET imaging in renal disease., J Nucl Med, 36, 1595

Thông tin
Thông tin xuất bản

Clinical Nuclear Medicine

Tập 40 Số 12

936-940

Thông tin tác giả